Withstanding the small sample size, the data we have generated suggests that the relationship between HMGB1, SCD, and PD-L1 may help clinicians stratify patients into groups based on the potential to predict the immunological sensitivity of tumors to current and future immunotherapies. Here, CD274 is linked to Schnyder corneal dystrophy.